Steven Cohen Ionis Pharmaceuticals Inc Transaction History

Point72 Asset Management, L.P.

$40.1 Billion
Q1 2025

A detailed history of Steven Cohen (Point72 Asset Management, L.P.) transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Point72 Asset Management, L.P. holds 287,204 shares of IONS stock, worth $10.1 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

287,204

Holding current value

$10.1 Million

% of portfolio

0.02%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$30.17 - $34.97 $8.66 Million - $10 Million	287,204 New	287,204 $8.66 Million
Q2 2024 Aug 14, 2024	SELL	$36.45 - $47.7 $5.45 Million - $7.13 Million	-149,392 Reduced 52.13%	137,210 $6.54 Million
Q1 2024 May 15, 2024	SELL	$42.03 - $53.55 $28.7 Million - $36.5 Million	-682,198 Reduced 70.42%	286,602 $12.4 Million
Q4 2023 Feb 14, 2024	BUY	$43.39 - $51.63 $35.9 Million - $42.7 Million	827,300 Added 584.66%	968,800 $49 Million
Q3 2023 Nov 14, 2023	SELL	$38.5 - $47.13 $2.42 Million - $2.96 Million	-62,900 Reduced 30.77%	141,500 $6.42 Million
Q2 2023 Aug 14, 2023	BUY	$34.73 - $43.33 $3.77 Million - $4.7 Million	108,515 Added 113.17%	204,400 $8.39 Million
Q1 2023 May 15, 2023	BUY	$33.58 - $41.2 $3.22 Million - $3.95 Million	95,885 New	95,885 $3.43 Million
Q2 2022 Aug 15, 2022	BUY	$31.71 - $43.0 $418,096 - $566,955	13,185 New	13,185 $488,000
Q1 2022 May 16, 2022	SELL	$29.88 - $37.04 $1.61 Million - $2 Million	-53,981 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$25.61 - $35.1 $4.23 Million - $5.8 Million	-165,319 Reduced 75.38%	53,981 $1.64 Million
Q3 2021 Nov 15, 2021	SELL	$33.54 - $40.55 $25.4 Million - $30.7 Million	-757,600 Reduced 77.55%	219,300 $7.36 Million
Q2 2021 Aug 16, 2021	BUY	$34.54 - $47.25 $33.7 Million - $46.2 Million	976,900 New	976,900 $39 Million
Q1 2021 May 17, 2021	SELL	$42.51 - $63.78 $17.1 Million - $25.7 Million	-402,400 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$45.3 - $60.27 $5.16 Million - $6.87 Million	113,908 Added 39.48%	402,400 $22.8 Million
Q3 2020 Nov 16, 2020	BUY	$47.45 - $62.95 $5.4 Million - $7.17 Million	113,867 Added 65.21%	288,492 $13.7 Million
Q2 2020 Aug 14, 2020	BUY	$46.85 - $61.05 $7.92 Million - $10.3 Million	169,052 Added 3033.41%	174,625 $10.3 Million
Q1 2020 May 15, 2020	BUY	$41.6 - $63.4 $231,836 - $353,328	5,573 New	5,573 $263,000
Q4 2018 Feb 14, 2019	SELL	$43.37 - $59.54 $3.73 Million - $5.12 Million	-86,031 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$42.88 - $53.7 $3.69 Million - $4.62 Million	86,031 New	86,031 $4.44 Million
Q4 2017 Feb 14, 2018	SELL	$50.3 - $64.39 $1.26 Million - $1.61 Million	-25,000 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$45.56 - $59.57 $1.14 Million - $1.49 Million	25,000	25,000 $1.27 Million

Others Institutions Holding IONS

# of Institutions

401

Shares Held

146M

Call Options Held

916K

Put Options Held

552K

View Full List

About IONIS PHARMACEUTICALS INC

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

More about IONS

Track Steven Cohen's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.

Account